- Reuters•12 hours ago
Sanofi has struck a collaboration deal with a leading Brazilian research institute to speed development of a Zika vaccine, consolidating the French drugmaker's position in the race to defeat the mosquito-borne virus. The deal with the Fiocruz public health centre follows a tie-up in July between Sanofi and a U.S. Army research institute, which gave the drugmaker access to one of the furthest advanced vaccines in development. Sanofi said on Thursday that all three research organisations would now work together to "increase the likelihood of successfully developing and licensing a safe and effective Zika vaccine as quickly as possible".
- GlobeNewswire•15 hours ago
Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research - The three research organizations have a history of flavivirus vaccine collaboration - Paris, France - October 27, 2016 ...
NYSE - NYSE Real Time Price. Currency in USD
|Bid||37.93 x 1400|
|Ask||37.94 x 1300|
|Day's Range||37.47 - 38.01|
|52wk Range||36.81 - 50.95|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.59|
|Avg Vol (3m)||2,319,450|
|Dividend & Yield||1.66 (4.45%)|